PE/Dazzle™ 594 anti-mouse CD31
Description
CD31 is a 130-140 kD glycoprotein, also known as platelet endothelial cell adhesion molecule (PECAM-1), EndoCAM, and gpIIa. It is a member of the Ig superfamily, expressed on endothelial cells, platelets, granulocytes, monocytes/macrophages, dendritic cells, and T and B cell subsets, and is critical for cell-to-cell interactions. The primary ligands for CD31 have been reported to be CD38 and the vitronectin receptor (αv β3 integrin, CD51/CD61). Other reported functions of CD31 are neutrophil emigration to sites of inflammation, and angiogenesis.
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.5 microg per million cells in 100 microL volume. It is recommended that the reagent be titrated for optimal performance for each application.
* PE/Dazzle™ 594 has a maximum excitation of 566 nm and a maximum emission of 610 nm.
This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.
References
1. Vecchi A, et al. 1994. Eur. J. Cell Biol. 63:247. (IP, IHC, Block)
2. Christofidou-Solomidou M, et al. 1997. J. Immunol. 158:4872. (Block)
3. DeLisser HM, et al. 1997. Am. J. Pathol. 151:671. (Block)
4. Rosenblum WI, et al. 1994. Am. J. Pathol. 145:33. (Block)
5. Baldwin HS, et al. 1994. Development 120:2539. (IHC)
6. Voswinckel R, et al. 2003. Circ. Res. 93:372. (IHC)
7. Leung VW, et al. 2009. Am J. Pathol. 175:1757. PubMed
8. Chacko AM, et al. 2012. PLoS One 7:e34958.
9. Giacomini C, et al. 2014. Exp Eye Res. 18:1. PubMed
10. Morita R, et al. 2015. PNAS. 112:160. PubMed
11. Ito A, et al. 2015. Brain Res. 1594:310. PubMed